Patient-centricity is a prominent buzzword but there is little consensus on the true purpose behind the engagement.
eyeforpharma has addressed, the WHAT, the WHY, and the HOW behind patient-centricity in our latest magazine:
- WHAT: Guy Yeoman, VP Patient Centricity at AstraZenecaspeaks about how they have come to publish the first definition of patient centricity, co-created with patients and carers
- WHY: Pfizer, Merck and GSK give us their perspectives on how being patient-centric will deliver BOTH patient and shareholder value
- HOW: We showcase some of the industry’s most impactful patient initiatives – this year’s eyeforpharma Award winners
Download you copy of the magazine here: https://goo.gl/IoJRaS